Education
About Us
Working with TipRanks
Follow Us
Innovation Pharma (IPIX)
:IPIX
IPIX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume37.05K
Average Volume (3M)N/A
Market Cap
$161.18K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-3.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding532,947,450
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innovation Pharmaceuticals News
IPIX FAQ
What was Innovation Pharma’s price range in the past 12 months?
Innovation Pharma lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Innovation Pharma’s market cap?
Innovation Pharma’s market cap is $161.18K.
When is Innovation Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Innovation Pharma’s earnings last quarter?
Currently, no data Available
Is Innovation Pharma overvalued?
According to Wall Street analysts Innovation Pharma’s price is currently Overvalued.
Does Innovation Pharma pay dividends?
Innovation Pharma does not currently pay dividends.
What is Innovation Pharma’s EPS estimate?
Innovation Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Innovation Pharma have?
Innovation Pharma has 532,947,450 shares outstanding.
What happened to Innovation Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Innovation Pharma?
Currently, no hedge funds are holding shares in IPIX
Company Description
Innovation Pharma
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Innovation Pharmaceuticals (IPIX) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---